MTAP and CDKN2B genes are associated with myocardial infarction in Chinese Hans

Clinical Biochemistry

Volumn 42, Issue 10-11, 2009, Pages 1071-1075

  Yang, Xin Chun ^a   Zhang, Qi ^a   Chen, Mu Lei ^a   Li, Qiang ^a   Yang, Zhong Su ^a   Li, Lei ^b   Cao, Fei Fei ^c,d   Chen, Xing Dong ^c,d   Liu, Wen Juan ^b   Jin, Li ^b,c   Wang, Xiao Feng ^b,c  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c CMC Institute of Health Sciences   (China)

^d SHANDONG UNIVERSITY   (China)

Author keywords

Association; Genetics; Myocardial infarction; Polymorphism

Indexed keywords

5' METHYLTHIOADENOSINE PHOSPHORYLASE; ADENINE; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B; GUANINE; LIPID;

ADULT; AGED; ALCOHOL CONSUMPTION; ALLELE; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHINESE; CIGARETTE SMOKING; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; CYCLIN-DEPENDENT KINASE INHIBITOR P15; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PURINE-NUCLEOSIDE PHOSPHORYLASE;

EID: 67349224012     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2009.02.021     Document Type: Article

References (22)

1. Helgadottir A., Thorleifsson G., Manolescu A., et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 316 (2007) 1491-1493
2. McPherson R., Pertsemlidis A., Kavaslar N., et al. A common allele on chromosome 9 associated with coronary heart disease. Science 316 (2007) 1488-1491
3. Wellcome Trust Case-control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447 (2007) 661-678
4. Samani N.J., Erdmann J., Hall A.S., et al. Genomewide association analysis of coronary artery disease. N Engl J Med 357 (2007) 443-453
5. Hinohara K., Nakajima T., Takahashi M., et al. Replication of the association between a chromosome 9p21 polymorphism and coronary artery disease in Japanese and Korean populations. J Hum Genet 53 (2008) 357-359
6. Shen G.Q., Li L., Rao S., et al. Four SNPs on chromosome 9p21 in a South Korean population implicate a genetic locus that confers high cross-race risk for development of coronary artery disease. Arterioscler Thromb Vasc Biol 28 (2008) 360-365
7. Zhou L., Zhang X.M., He M.A., et al. Associations between single nucleotide polymorphisms on chromosome 9p21 and risk of coronary heart disease in Chinese Han population. Arterioscler Thromb Vasc Biol 28 (2008) 2085-2089
8. Lowe S.W., and Sherr C.J. Tumor suppression by Ink4a-Arf: progress and puzzles. Curr Opin Genet Dev 13 (2003) 77-83
9. Hannon G.J., and Beach D. p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature 371 (1994) 257-261
10. Kalinina N., Agrotis A., Antropova Y., et al. Smad expression in human atherosclerotic lesions: evidence for impaired TGFbeta/Smad signaling in smooth muscle cells of fibrofatty lesions. Arterioscler Thromb Vasc Biol 24 (2004) 1391-1396
11. Johnson G.C., Esposito L., Barratt B.J., et al. Haplotype tagging for the identification of common disease genes. Nat Genet 29 (2001) 233-237
12. Boom R., Sol C.J., Salimans M.M., et al. Rapid and simple method for purification of nucleic acids. J Clin Microbiol 28 (1990) 495-503
13. Bell PA, Chaturvedi S, Gelfand CA, et al. SNPstream UHT: ultra-high throughput SNP genotyping for pharmacogenomics and drug discovery. Biotechniques 2002; Suppl: 70-2, 74, 76-7.
14. Stephens M., Smith N.J., and Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68 (2001) 978-989
15. Barrett J.C., Fry B., Maller J., and Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 (2005) 263-265
16. Hamsten A., and Eriksson P. Identifying the susceptibility genes for coronary artery disease: from hyperbole through doubt to cautious optimism. J Intern Med 263 (2008) 538-552
17. Mazumder B., Sampath P., Seshadri V., Maitra R.K., DiCorleto P.E., and Fox P.L. Regulated release of L13a from the 60S ribosomal subunit as a mechanism of transcript-specific translational control. Cell 115 (2003) 187-198
18. Conne B., Stutz A., and Vassalli J.D. The 30 untranslated region of messenger RNA: a molecular _hotspot_ for pathology?. Nat Med 6 (2000) 637-641
19. Guhaniyogi J., and Brewer G. Regulation of mRNA stability in mammalian cells. Gene 265 (2001) 11-23
20. Tunstall-Pedoe H., Kuulasmaa K., Amouyel P., Arveiler D., Rajakangas A.M., and Pajak A. Myocardial infarction and coronary deaths in the world health organization MONICA project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 90 (1994) 583-612
21. Paech K., Webb P., Kuiper G.G., et al. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science 277 (1997) 1508-1510
22. Cerillo G., Rees A., Manchanda N., et al. The oestrogen receptor regulates NFkappaB and AP-1 activity in a cell-specific manner. J Steroid Biochem Mol Biol 67 (1998) 79-88